Used in pharmaceutical research as a chiral intermediate for synthesizing beta-blocker analogs. Its structure supports the development of cardioselective agents with improved metabolic stability. Also explored in the design of enzyme inhibitors due to its ability to mimic transition states in hydrolytic reactions. Shows potential in asymmetric synthesis for producing enantiomerically pure drugs.